enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Treatment and management of COVID-19 - Wikipedia

   en.wikipedia.org/wiki/Treatment_and_management...

   The treatment and management of COVID-19 combines both supportive care, which includes treatment to relieve symptoms, fluid therapy, oxygen support as needed, [1][2][3] and a growing list of approved medications. Highly effective vaccines have reduced mortality related to SARS-CoV-2; however, for those awaiting vaccination, as well as for the ...

3. What Doctors Want Those Over 65 to Know About Getting the ...

   www.aol.com/doctors-want-those-over-65-113000100...

   The CDC’s new COVID-19 vaccine recommendations suggest a second dose of the updated COVID-19 vaccine for people who are 65+, as well as those who are moderately or severely immunocompromised ...

4. Most say they probably won’t get updated COVID vaccine: Survey

   www.aol.com/most-probably-won-t-updated...

   Most Americans in a new poll said they probably won’t get an updated COVID-19 vaccine. The Pew Research Center survey found that 60 percent said they are “probably not” going to “get an ...

5. Casirivimab/imdevimab - Wikipedia

   en.wikipedia.org/wiki/Casirivimab/imdevimab

   In the European Union, the combination is indicated for the treatment of COVID‑19 in people aged twelve years of age and older weighing at least 40 kilograms (88 lb) who do not require supplemental oxygen and who are at high increased risk of progressing to severe COVID‑19; [10] and for the prevention of COVID‑19 in people aged twelve years of age and older weighing at least 40 kilograms ...

6. COVID-19 vaccine clinical research - Wikipedia

   en.wikipedia.org/wiki/COVID-19_vaccine_clinical...

   A Phase 1/2 Study to Assess the Safety, Immunogenicity and Recommended Dose of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects. Mar 2021 – Jul 2022, Japan: GBP510 SK Bioscience Co. Ltd., GSK: South Korea, United Kingdom Subunit (Recombinant protein nanoparticle with adjuvanted with AS03) Phase III (4,000) [112]

7. What to know about Dr. Oz as Trump picks him to lead Centers ...

   www.aol.com/news/know-dr-oz-trump-picks...

   In June 2020, the U.S. Food and Drug Administration revoked emergency authorization for hydroxychloroquine and chloroquine to treat COVID-19, saying evidence shows the recommended dose is unlikely ...

8. SARS-CoV-2 - Wikipedia

   en.wikipedia.org/wiki/SARS-CoV-2

   t. e. Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) [2] is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. [3] The virus previously had the provisional name 2019 novel coronavirus (2019-nCoV), [4][5][6][7] and has also been called human coronavirus 2019 (HCoV-19 or ...

9. Nirmatrelvir/ritonavir - Wikipedia

   en.wikipedia.org/wiki/Nirmatrelvir/ritonavir

   No participants had received a COVID‑19 vaccine or been previously infected with COVID‑19. [12] The main outcome measured in the trial was the proportion of people who were hospitalized due to COVID‑19 or died due to any cause during 28 days of follow-up. [12] EPIC-HR started in July 2021, and completed in December 2021. [49]